North America $1.4 Billion Organoids Market to 2027 - Emergence of Three-dimensional (3-D) Organoids

Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "North America Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Application, and Source, and Country" report has been added to ResearchAndMarkets.com's offering.

North America Organoids Market is projected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019.

The market is estimated to grow at CAGR of 21.7% from 2020 to 2027. The report highlights trends prevailing in the North America organoids market and the factors driving market along with those that act as hindrances.

Based on type, the North America organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and lung. In 2019, the intestine organoids segment accounted for the global organoids markets largest market share. The intestine organoids segment holds a significant market share in the organoids market due to rise in prevalence of inflammatory bowel diseases (IBD).

Also, the significant adoption of new technologies among researchers and academia; coupled with growing industry-academia collaborations for research, and technological advancements in 3D bioprinting will further offer lucrative opportunities in the review period.

The North America organoids market is expected to grow owing to factors such as emergence of three-dimensional (3-D) organoids, and growing investments in research. However, lack of skilled professionals is likely to restraint the market growth during the forecast period.

STEMCELL Technologies Inc; Definigen; 3Dnamics Inc; Organoid Therapeutics; PeproTech, Inc; THERMO FISHER SCIENTIFIC INC; Corning Incorporated, and MERCK KGaA are among the leading companies operating in the North America organoids market.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation

2. Organoids Market - Key Takeaways

3. Research Methodology

4. Organoids - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion

5. North America Organoids Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Emergence of Three-dimensional (3-D) Organoids
5.1.2 Growing Investments in Research
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Opportunities to Use Organoids as Aging Model
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis

6. Organoids Market - Regional Analysis
6.1 North America Organoids Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players

7. Organoids Market Analysis - By Type
7.1 Overview
7.2 Organoids Market Revenue Share, by Type, 2019 and 2027 (%)
7.2.1 North America Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
7.3 Stomach
7.4 Intestine
7.5 Liver
7.6 Pancreas
7.7 Lung
7.8 Brain
7.9 Kidney

8. Organoids Market - By Application
8.1 Overview
8.2 Organoids Market, by Application, 2019 and 2027 (%)
8.2.1 North America Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.3 Developmental Biology
8.4 Disease Pathology of Infectious Disease
8.5 Regenerative Medicine
8.6 Drug Toxicity and Efficacy Testing
8.7 Drug Discovery and Personalized Medicine

9. Organoids Market - By Source
9.1 Overview
9.2 Organoids Market, by Source, 2019 and 2027 (%)
9.3 Pluripotent Stem Cells
9.4 Organ-Specific Adult Stem Cells

10. Organoids Market- Regional Analysis
10.1 North America: Organoids Market

11. Impact of COVID-19 Pandemic on North America Organoids Market
11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Key Company Profiles

• STEMCELL Technologies Inc

• Definigen

• 3Dnamics Inc

• Organoid Therapeutics

• PeproTech, Inc

• Thermo Fisher Scientific Inc

• Corning Incorporated

• MERCK KGaA

For more information about this report visit https://www.researchandmarkets.com/r/76s0m7

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900